Surgery Partners Management

Management Kriterienprüfungen 3/4

Surgery Partners' CEO ist J. Evans , ernannt in Jan 2020, hat eine Amtszeit von 4.42 Jahren. Die jährliche Gesamtvergütung beträgt $6.46M , bestehend aus 16.3% Gehalt und 83.7% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.36% der Aktien des Unternehmens, im Wert von $11.55M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.9 Jahre bzw. 6.1 Jahre.

Wichtige Informationen

J. Evans

Geschäftsführender

US$6.5m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts16.3%
Amtszeit als Geschäftsführer4.7yrs
Eigentum des Geschäftsführers0.4%
Durchschnittliche Amtszeit des Managements3.2yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder6.4yrs

Jüngste Management Updates

We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

May 31
We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

Recent updates

Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward

Jul 25
Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward

Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Jul 13
Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

Jun 21
Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

May 31
We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Apr 24
Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Mar 18
Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Feb 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Dec 19
The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Oct 26
Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Sep 17
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

Aug 26
Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Jul 21
The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

Jun 15
Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

May 26
A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Apr 14
There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Mar 24
Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jan 24
Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

Sep 26
We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Aug 15
The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Surgery Partners GAAP EPS of -$0.21 misses by $0.07, revenue of $615.4M misses by $3.61M

Aug 02

Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders

Jul 02

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Jun 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Mar 27
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von J. Evans im Vergleich zu den Einnahmen von Surgery Partners verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

-US$34m

Mar 31 2024n/an/a

US$600k

Dec 31 2023US$6mUS$1m

-US$12m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

-US$54m

Mar 31 2023n/an/a

-US$92m

Dec 31 2022US$6mUS$1m

-US$55m

Sep 30 2022n/an/a

-US$31m

Jun 30 2022n/an/a

-US$29m

Mar 31 2022n/an/a

-US$38m

Dec 31 2021US$4mUS$1m

-US$81m

Sep 30 2021n/an/a

-US$86m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$150m

Dec 31 2020US$4mUS$916k

-US$156m

Sep 30 2020n/an/a

-US$179m

Jun 30 2020n/an/a

-US$132m

Mar 31 2020n/an/a

-US$119m

Dec 31 2019US$5mUS$435k

-US$110m

Vergütung im Vergleich zum Markt: J.Die Gesamtvergütung ($USD6.46M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD6.84M).

Entschädigung vs. Einkommen: J.Die Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.


Geschäftsführer

J. Evans (47 yo)

4.7yrs

Amtszeit

US$6,457,600

Vergütung

Mr. J. Eric Evans has been the Chief Executive Officer and Director of Surgery Partners, Inc. since January 13, 2020 and served as its Executive Vice President and Chief Operating Officer since April 1, 20...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Wayne DeVeydt
Executive Chairman6.7yrsUS$250.00k0.080%
$ 3.3m
J. Evans
CEO & Director4.7yrsUS$6.46m0.36%
$ 14.8m
David Doherty
Executive VP & CFO2.6yrsUS$3.52m0.076%
$ 3.1m
Jennifer Baldock
Executive VP and Chief Administrative & Development Officer4.6yrsUS$3.09m0.15%
$ 5.9m
Bradley Owens
President of National Group4.8yrsUS$1.61m0.057%
$ 2.3m
Marissa Brittenham
Executive VP & Chief Strategy Officer2.7yrsUS$1.68m0.031%
$ 1.3m
Neil Zieselman
Senior Vice President of Corporate Finance & Controller2.3yrskeine Datenkeine Daten
Varun Gadhok
Senior VP & Chief Information Officer3.2yrskeine Datenkeine Daten
Roxanne Womack
Senior VP & Chief Compliance Officer5.8yrskeine Datenkeine Daten
Spencer Clark
General Counsel & Senior VPless than a yearkeine Datenkeine Daten
Danielle Burkhalter
Executive VP & Chief Human Resources Officer1.6yrskeine Daten0.024%
$ 977.9k
Anthony Taparo
Chief Growth Officer5.1yrsUS$1.30m0.081%
$ 3.3m

3.2yrs

Durchschnittliche Betriebszugehörigkeit

52yo

Durchschnittliches Alter

Erfahrenes Management: SGRYDas Führungsteam des Unternehmens gilt als erfahren (2.9 Jahre durchschnittliche Betriebszugehörigkeit).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Wayne DeVeydt
Executive Chairman6.7yrsUS$250.00k0.080%
$ 3.3m
J. Evans
CEO & Director4.7yrsUS$6.46m0.36%
$ 14.8m
Clifford Adlerz
Director6.9yrsUS$260.00k0.040%
$ 1.6m
Blair Hendrix
Director3.3yrskeine Datenkeine Daten
William Turner
Independent Director8.8yrsUS$285.00k0.054%
$ 2.2m
Patricia Maryland
Independent Director3.6yrsUS$260.00k0.014%
$ 570.8k
Teresa DeLuca
Independent Director8yrsUS$280.00k0.046%
$ 1.9m
John Deane
Independent Director5.3yrsUS$260.00k0.022%
$ 882.2k
T. O'Reilly
Director7.1yrskeine Datenkeine Daten
Andrew Kaplan
Director6.1yrskeine Datenkeine Daten

6.4yrs

Durchschnittliche Betriebszugehörigkeit

58yo

Durchschnittliches Alter

Erfahrener Vorstand: SGRYDie Vorstandsmitglieder gelten als erfahren (6.1 Jahre durchschnittliche Amtszeit).